FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Explores AI Image Analysis for Complex Drugs

FDA explores whether it can enter into a five-year contract with an entity that can perform non-invasive high-resolution imaging and artificial intell...

latest-news-card-1
Human Drugs

Boost Faith in Accelerated Approvals: Researchers

Yale University researchers suggest five steps FDA could consider to help build patient and clinician trust in drug accelerated approvals.

latest-news-card-1
Biologics

RSVpreF Vaccine Meets Endpoints

Pfizer-supported research shows its investigational bivalent RSV prefusion F protein-based vaccine succeeded in preventing RSV-associated lower respir...

latest-news-card-1
Human Drugs

Mutagenic Impurities Guideline Adopted

The International Council for Harmonization gives final approval to a guidance on assessing and controlling mutagenic impurities in drugs to limit can...

latest-news-card-1
Medical Devices

FDA Wants MDUFA 5 PPI Input

FDA asks for input on five questions that could be included in a revision of a medical device patient perspective guidance.

latest-news-card-1
Federal Register

Comments Extended on Neurodevelopmental Study Guide

Federal Register notice: FDA extends the comment period for a draft guidance entitled Considerations for Long-Term Clinical Neurodevelopmental Safety ...

latest-news-card-1
Biologics

Untitled Letter Sent to Fidia Pharma

CBER issues an untitled letter to Fidia Pharma USA after reviewing the companys Web sites and determining that its cell/tissue products require a BLA ...

latest-news-card-1
Federal Register

Guide on Clinical Outcome Assessments

Federal Register notice: FDA makes available a draft guidance on incorporating clinical outcome assessments into endpoints.

latest-news-card-1
Federal Register

Guide on Drug Mfg. Discontinuance/Interruptions

Federal Register notice: FDA makes available a draft guidance entitled Notification of a Permanent Discontinuance or Interruption in Manufacturing Und...

latest-news-card-1
Human Drugs

FDA Pulls Makena Approval Immediately

FDA commissioner Robert Califf and chief scientist Namandj Bumpus withdraw Covis Pharmas preterm birth drug Makena and its generics from the market ef...